Fish Oil, Vitamin C and Vitamin E: study protocols
5 study groups took Fish Oil together with Vitamin C and Vitamin E. These are the doses the studies gave. They are not a recommendation.
Dose per serving from research: Fish Oil
5 study groups in 4 studies say how much Fish Oil participants took a day.
These are the doses the studies gave. They are not a recommendation.
Most common: 500 mg to 1 g and 2.5 g to 5 g, 40% of 5 study groups each.
| Daily dose | Study groups |
|---|---|
| 500 mg to 1 g | 2 |
| 1 g to 2.5 g | 1 |
| 2.5 g to 5 g | 2 |
Commonly used together
5 of 5 study groups took Fish Oil, Vitamin C and Vitamin E with something else, but nothing that 3 or more different studies gave.
5 study groups
| Study | |||||
|---|---|---|---|---|---|
| Wrinkle reduction in post-menopausal women consuming a novel oral supplement: a double-blind placebo-controlled randomized study 2014 · Test group 1 · Healthy, non-smoking post-menopausal women, skin types I–III, not receiving HRT and with BMI 18–33 kg/m² | 660 mg | 250 mg | 250 mg | 14 weeks | 55 |
| Wrinkle reduction in post-menopausal women consuming a novel oral supplement: a double-blind placebo-controlled randomized study 2014 · Test group 2 · Healthy, non-smoking post-menopausal women, skin types I–III, not receiving HRT and with BMI 18–33 kg/m² | 660 mg | 180 mg | 30 mg | 14 weeks | 55 |
| Fish oil and antioxidants alter the composition and function of circulating mononuclear cells in Crohn disease 2004 · fish-oil group · Patients with Crohn disease and raised C-reactive protein concentrations or erythrocyte sedimentation rates; age and sex not stated | 2.7 g | — | — | 24 weeks | 31 |
| High-dose fish oil and antioxidants in Crohn's disease and the response of bone turnover: a randomised controlled trial 2005 · fish oil plus antioxidants · Patients with Crohn's disease and currently or recently raised biochemical markers of inflammation | 2.7 g | — | — | 24 weeks | 31 |
| Omega-3 supplementation combined with anti-vascular endothelial growth factor lowers vitreal levels of vascular endothelial growth factor in wet age-related macular degeneration 2014 · Group 1 (Vitalux plus Omega-3) · Adults with active wet age-related macular degeneration who had previously received anti-VEGF treatment | 1.05 g | 500 mg | 400 IU | — | 10 |